SI-BONE, Inc. (NASDAQ:SIBN) Receives Consensus Recommendation of Buy from Brokerages

Shares of SI-BONE, Inc. (NASDAQ:SIBN – Get Rating) have earned a consensus rating of “Buy” from the seven research firms that are presently covering the firm, Marketbeat reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have updated their coverage on the stock […]

Related Keywords

Michaela Pisetsky ,Jeffreyw Dunn , ,Needham Company ,Nasdaq ,Canaccord Genuity Group ,Tower Research Capital ,Company Profile ,Morgan Stanley ,Larson Financial Group ,Cantor Fitzgerald ,Securities Exchange Commission ,Ensign Peak Advisors Inc ,Get Rating ,Genuity Group ,Truist Financial ,Exchange Commission ,Director Jeffrey ,Financial Group ,Peak Advisors Inc ,Research Capital ,Si Bone ,Nasdaq Sibn ,Sibn ,Medical ,Ratings ,Consensus ,